Adamis Pharma up on NIH grant for alcohol use disorder treatment

DMK Pharmaceuticals

26/06/2023 13:39

** Shares of drug maker Adamis Pharmaceuticals Corp  ADMP.O 
up 8.8% at $2.22 before the bell
    ** ADMP reports its subsidiary is the recipient of a grant
from one of the institutes of the National Institutes of Health
(NIH) for treatment of alcohol use disorder (AUD)
    ** The grant to co's subsidiary DMK Pharmaceuticals Corp is
to support development of a novel bi-functional small molecule
for AUD treatment 
    ** As of last close, stock lost 82.8% YTD
    

 (Reporting by Pratik Jain in Bengaluru)
 ((Pratik.Jain@thomsonreuters.com;))